Latest Breaking News On - ஐரோப்பிய கூட்டணி ஆஃப் சங்கங்கள் - Page 5 : comparemela.com

Photo: Getty Images By Contributor 11th May 2021 The treatment of Rheumatoid Arthritis has been transformed in the last two decades by the introduction of biologic agents. Dr Sharon Cowley looks at how management and treatment of RA has changed Rheumatoid Arthritis (RA) is a common condition, estimated to affect 1% of the caucasian population and over 45,000 people in Ireland.1 It results from a complex interaction between genes and environment, leading to a breakdown of immune tolerance and synovial inflammation in a characteristic symmetric pattern. Each year in Ireland 2,000 new cases are diagnosed, and 3 out of 4 are in patients of working age. There have been many recent advances in the treatment of RA and new treatment strategies have substantially changed the course of RA. Many patients can achieve remission if the disease is recognised early, and it is treated promptly and continuously.

Munizr adalimumab biosimilarsTatsuya koikeSharon cowleyEuropean alliance of associationsEuropean medicines agencyAmerican college of rheumatologyIrish pharmaceutical healthcare associationRheumatoid arthritisEuropean allianceAmerican collegeSynthetic disease modifying anti rheumatic agentKinase inhibitorsRheumatic diseasesRheumatology guidelineRheum disSystematic review